本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neumora Therapeutics, Inc.

2.15
+0.15007.50%
盤後2.150.00000.00%19:40 EDT
成交量:141.98萬
成交額:297.41萬
市值:3.91億
市盈率:-1.48
高:2.19
開:2.04
低:1.99
收:2.00
52周最高:3.65
52周最低:0.6110
股本:1.82億
流通股本:9,555.91萬
量比:1.27
換手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-1.4501
每股收益(LYR):-1.4501
淨資產收益率:-121.21%
總資產收益率:-58.11%
市淨率:3.77
市盈率(LYR):-1.48

資料載入中...

2025/05/12

重要事件披露

Form 8-K - Current report
2025/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/11

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

重要事件披露

Form 8-K - Current report
2024/11/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors